BANDICOOT is an international adaptive platform trial (APT) designed to identify effective therapies that improve health outcomes for critically ill children receiving a haematopoetic stem cell transplant (HCT). Building
on extensive engagement with patients, their parents, and clinicians, we will launch 3 trial domains focused on exercise, nutritional supplementation, and the gut microbiome
Mental health risk assessments have always been a challenge, even for the most experienced clinicians. Risk assessment involves understanding not just the severity of the reported symptoms but the underlying motivations and the psychosocial circumstances.
This year’s NAIDOC theme is The Next Generation: Strength, Vision, and Legacy. Drawing on these words, Commissioner Meena Singh will discuss her work at the Commission for Children and Young People, the importance of hearing and acting upon the voices of Aboriginal children and young people, and how ensuring their safety, and supporting their growth, means we are investing in our future.
Professor Joseph Dearani from the Mayo Clinic is a world-renowned cardiac surgeon, and expert in management of patients with hypertrophic cardiomyopathy. He has accumulated the world’s largest experience with surgical management of these complex patients, and will discuss the lessons.
How prepared are we for disasters in 2025? Do we need state and national standards for disaster response teams?
Immunisations are one of the world’s greatest public health interventions, and also one of the areas of medicine increasingly susceptible to misinformation. Independent, evidence-based scientific advice to governments and the community is crucial in informing immunisation policy and appropriate utilisation and uptake of safe and effective vaccines.
Advances in medical care and changes in societal expectations have resulted in different patterns of survival for children and adolescents with severe neurological disability. Increased longevity, new and unseen multi-morbidity, and access to an increasing array of new and often invasive interventions offers significant decision-making challenges to children, parents, and clinicians. Sometimes it is not clear if we are helping or harming.
Genomics has moved rapidly from being purely a research tool to being part of routine care in many specialities and health services. Past Grand Round presenters have described how this has enhanced their service – how genomic care may improve patient outcomes, is cost-effective and can be delivered rapidly for acute cases.
Trauma-Informed Preventative Care (TIPC) is shaping the way we support children, young people, families, and staff across The Royal Children’s Hospital.
In the last decade, we have seen genetic therapies leap from the benchtop into the neuromuscular clinic. This process is most dramatically illustrated by spinal muscular atrophy (SMA), which was until recently the most common genetic cause of death in infancy.
